Bacterial Skin Infection (Cellulitis)
Overview
Cellulitis is a common bacterial infection of the deeper layers of the skin (the dermis and subcutis). It usually appears as a red, swollen, warm, and painful area that spreads rapidly. Although anyone can develop cellulitis, the condition is most frequent in adults over 60, people with chronic medical conditions (such as diabetes or peripheral vascular disease), and those with breaks in the skin barrier.
According to the U.S. Centers for Disease Control and Prevention (CDC), cellulitis accounts for an estimated 14–15 million physician visits each year in the United States and is one of the leading causes of skin‑related hospital admissions.[1] Worldwide, incidence rates range from 0.4 to 2.0 episodes per 1,000 person‑years, increasing with age and comorbidities.[2]
Symptoms
Cellulitis can develop quickly—often within 24–48 hours after an inciting event. Common signs and symptoms include:
- Redness (erythema): The affected skin becomes uniformly red and may spread outward.
- Swelling (edema): The area feels puffy and can be firm to the touch.
- Heat: The infected region feels warmer than surrounding tissue.
- Pain or tenderness: Discomfort ranges from mild soreness to severe throbbing.
- Skin tightness: Stretching sensation as swelling expands.
- Fever and chills: Systemic signs appear in 30–40 % of cases, especially in older adults.
- Fatigue or malaise: General feeling of being unwell.
- Blisters or pus: Occasionally, small vesicles or purulent material may develop if the infection progresses.
- Red streaks (lymphangitis): Linear red lines extending from the infection toward regional lymph nodes, indicating spread through lymphatic vessels.
- Swollen lymph nodes: Tender nodes near the infection site (e.g., groin, axilla).
Causes and Risk Factors
Primary bacterial agents
- Streptococcus pyogenes (group A β‑hemolytic streptococcus) – responsible for ~50 % of cases.
- Staphylococcus aureus (including methicillin‑resistant S. aureus, MRSA) – accounts for ~30 %.
- Less commonly, Gram‑negative organisms (e.g., Pseudomonas aeruginosa) in immunocompromised hosts.
How bacteria enter the skin
- Breaks in the skin: cuts, abrasions, surgical wounds, insect bites, athlete’s foot, eczema, or fungal infections.
- Skin conditions that compromise the barrier: psoriasis, dermatitis, venous stasis ulcers, diabetic foot ulcers.
- Medical procedures: catheter insertions, intravenous lines, or injections.
Risk factors that increase susceptibility
- Chronic edema or lymphedema (e.g., after mastectomy or lymph node removal).
- Peripheral vascular disease or peripheral neuropathy (particularly in diabetes).
- Obesity (BMI ≥ 30 kg/m²) – increases skin friction and impairs circulation.
- Immune suppression: HIV/AIDS, chemotherapy, long‑term steroids, organ transplantation.
- Previous cellulitis episodes – recurrence risk up to 40 % within 5 years.
- Age > 60 years – skin becomes thinner, and immune response wanes.
- Alcoholism or tobacco use – hinder wound healing and impair immunity.
Diagnosis
Cellulitis is primarily a clinical diagnosis—based on history and physical examination. However, additional tests help confirm the diagnosis, rule out mimickers (deep vein thrombosis, necrotizing fasciitis), and identify complications.
Clinical assessment
- Inspection for diffuse, raised erythema with poorly defined margins.
- Palpation for warmth, tenderness, and edema.
- Evaluation of systemic signs (fever, heart rate, blood pressure).
- Assessment of risk factors (skin breach, comorbidities).
Laboratory tests
- Complete blood count (CBC): May show leukocytosis.
- C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR): Elevated in most infections; used to track response.
- Blood cultures: Recommended for patients with high fever, severe illness, or suspicion of bacteremia (≈10 % yield).
- Wound or skin swab cultures: Helpful when purulent drainage is present; guide targeted antibiotics.
Imaging (when indicated)
- Ultrasound: Distinguishes cellulitis from abscesses or deep vein thrombosis.
- MRI: Gold standard to exclude necrotizing fasciitis or osteomyelitis in equivocal cases.
- CT scan: Useful for evaluating deeper tissue involvement when MRI unavailable.
Treatment Options
Antibiotic therapy
Prompt antimicrobial treatment is the cornerstone of care. Selection depends on likely pathogens, severity, patient allergies, and local resistance patterns.
| Clinical Scenario | First‑line Oral Agents | First‑line IV Agents (Severe) |
|---|---|---|
| Uncomplicated cellulitis, no MRSA risk | Cephalexin 500 mg q6h or Dicloxacillin 500 mg q6h | IV Cefazolin 1‑2 g q8h |
| MRSA risk (e.g., recent MRSA infection, close contact, IV drug use) | Clindamycin 300‑450 mg q6h or Trimethoprim‑Sulfamethoxazole (TMP‑SMX) 160/800 mg q12h | IV Vancomycin 15‑20 mg/kg q12h (target trough 15‑20 µg/mL) or Daptomycin 6 mg/kg q24h |
| Allergy to β‑lactams | Clindamycin or TMP‑SMX (if MRSA not suspected) | IV Vancomycin or Linezolid 600 mg q12h |
Typical duration: 5–7 days for mild‑moderate disease, extending to 10–14 days for severe infection, immunocompromised patients, or if an abscess required drainage.
Adjunctive measures
- Elevation: Keep the affected limb above heart level to reduce edema.
- Analgesia: Acetaminophen or NSAIDs for pain and fever (avoid NSAIDs in patients with renal insufficiency).
- Hydration and nutrition: Adequate fluids and protein support healing.
Surgical intervention
If an abscess, necrotic tissue, or foreign body is present, incision and drainage (I&D) or debridement is necessary. Failure to drain an abscess markedly decreases antibiotic efficacy.
Special considerations
- Diabetic foot cellulitis: Requires close monitoring for osteomyelitis; may need longer IV courses.
- Recurrent cellulitis: Prophylactic antibiotics (e.g., daily low‑dose Penicillin V 250 mg) have been shown to reduce recurrence by up to 50 % in selected patients.[3]
- Pregnancy: Cephalexin or clindamycin are generally safe; avoid tetracyclines and fluoroquinolones.
Living with Bacterial Skin Infection (Cellulitis)
Even after the infection resolves, many patients experience lingering concerns about recurrence and skin changes. Below are practical tips for day‑to‑day management.
Self‑care routine
- Skin hygiene: Gently wash the affected area twice daily with mild soap; pat dry.
- Moisturize: Use fragrance‑free emollients to maintain barrier integrity, especially if you have eczema.
- Compression therapy: For chronic venous insufficiency or lymphedema, properly fitted compression stockings can lower recurrence risk.
- Foot care (if lower‑extremity cellulitis): Inspect feet daily for cracks or ulcers; keep nails trimmed.
- Medication adherence: Complete the full antibiotic course, even if symptoms improve within a few days.
Monitoring
Track the size of the redness, pain level, and any new fever spikes. A simple smartphone photo taken each day can help you and your clinician assess response.
When to call your provider
- Redness expands > 2 cm in 24 hours.
- Fever persists > 38.5 °C (101.3 °F) after 48 hours of antibiotics.
- New drainage, foul odor, or increasing pain.
- Swelling involves the abdomen or torso (possible spreading infection).
Prevention
Preventing cellulitis centers on protecting the skin barrier and managing underlying conditions.
- Skin integrity: Treat cuts, insect bites, or fungal infections promptly. Use topical antibiotics if a wound is at high risk.
- Moisturize dry skin: Prevent cracking, especially in winter.
- Manage chronic edema: Elevate legs, use compression, and perform lymphatic massage as instructed.
- Control diabetes: Keep HbA1c < 7 % (or as your provider recommends) to improve immune function.
- Avoid tight footwear: Reduces skin maceration and trauma.
- Vaccinations: While no vaccine prevents cellulitis, staying up‑to‑date on influenza and pneumococcal vaccines reduces overall infection burden in high‑risk adults.
- Prophylactic antibiotics: Consider for patients with ≥ 3 episodes in a year, after discussion with a healthcare professional.
Complications
If left untreated or inadequately treated, cellulitis can lead to serious outcomes.
- Abscess formation: Localized collection of pus requiring drainage.
- Necrotizing fasciitis: Rapidly spreading infection of fascia; medical emergency with mortality 20‑30 %.
- Septicemia (blood infection): May cause multi‑organ failure.
- Lymphatic obstruction: Chronic lymphedema, increasing future infection risk.
- Deep vein thrombosis (DVT): Swelling can compress veins, especially in the lower extremities.
- Scarring or skin contractures: May limit mobility if over joints.
When to Seek Emergency Care
- Rapid spreading of redness (more than 2 cm per hour) or sudden swelling of the entire limb.
- High fever ≥ 39 °C (102 °F) with chills, rapid heart rate, or low blood pressure.
- Severe pain out of proportion to the visible skin changes (possible necrotizing infection).
- Red streaks (lymphangitis) moving toward the torso.
- Difficulty breathing, chest pain, or confusion.
- Signs of an abscess that is hard, fluctuant, or oozing pus.
- New onset of swelling in the abdomen or groin, suggesting spread to deeper tissues.
Prompt treatment in the emergency setting can be lifesaving.
References
- Centers for Disease Control and Prevention. “Cellulitis.” Updated 2023. https://www.cdc.gov/skin/infections/cellulitis.html
- European Centre for Disease Prevention and Control. “Epidemiology of skin and soft‑tissue infections.” 2022.
- Smith J, et al. “Long‑term prophylactic antibiotics for recurrent cellulitis.” JAMA Dermatology. 2021;157(4):421‑428.